Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Gene Therapy for Fanconi Anemia in Seattle: Clinical Experience and Next Steps

Jennifer E Adair, PhD, Pamela S. Becker, MD PhD, Devikha Chandrasekaran, MSc, Grace Choi, BS, Ann E Woolfrey, MD, Lauri Burroughs, MD, Hans-Peter Kiem, MD FACP

Blood (2016) 128 (22): 3510.

https://doi.org/10.1182/blood.V128.22.3510.3510

Published: 2016

Journal Articles

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

Brenda M Sandmaier, MD, David G Maloney, MD PhD, Barry E. Storer, PhD, Gitte Olesen, MD, Michael B. Maris, MD, Jonathan A Gutman, MD, Soren Lykke Petersen, MD DMSC, Amelia Langston, MD, Thomas Chauncey, Wolfgang Bethge, MD, Michael A Pulsipher, MD, Brian Thomas Kornblit, MD PhD, Ann E Woolfrey, MD, Marco Mielcarek, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD, Rainer F. Storb, MD

Blood (2016) 128 (22): 506.

https://doi.org/10.1182/blood.V128.22.506.506

Published: 2016

Journal Articles

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

Blood (2016) 128 (22): 985.

https://doi.org/10.1182/blood.V128.22.985.985

Published: 2016

Journal Articles

5 Year Results of BMT CTN 0201: Unrelated Donor Bone Marrow Is Associated with Better Psychological Well-Being and Less Burdensome Chronic Gvhd Symptoms Than Peripheral Blood

Stephanie J. Lee, MD MPH, Brent Logan, PhD, Peter Westervelt, MD PhD, Corey S Cutler, MD MPH, Ann E Woolfrey, MD, Shakila Khan, MD, Edmund K Waller, MD PhD, Richard T. Maziarz, MD, Juan Wu, Bronwen E. Shaw, MBChB, PhD MRCP, MRCPath, Dennis L. Confer, MD, Mary M. Horowitz, MD MS, Claudio Anasetti, MD

Blood (2015) 126 (23): 270.

https://doi.org/10.1182/blood.V126.23.270.270

Published: 2015

Journal Articles

Minimal Residual Disease Does Not Impact Risk of Relapse in Myeloablative Umbilical Cord Blood Transplant Recipients: Comparison with Matched and Mismatched Unrelated Transplants

Filippo Milano, MD PhD, Ted A. Gooley, PhD, Brent L. Wood, MD PhD, Ann E Woolfrey, MD, Effie W. Petersdorf, MD, Frederick R. Appelbaum, MD, Colleen Delaney, MD MSC

Blood (2014) 124 (21): 2579.

https://doi.org/10.1182/blood.V124.21.2579.2579

Published: 2014

Journal Articles

Role of Comorbidities in Prognostic Evaluation of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-Mismatched (MM) and Umbilical Cord Blood (UCB) Donor Grafts

Mahmoud Elsawy, MD MSc, Barry E. Storer, PhD, Brenda M. Sandmaier, MD, Colleen Delaney, MD MSC, Frederick R. Appelbaum, MD, Ann E Woolfrey, MD, David G Maloney, MDPhD, Rainer F. Storb, MD, Mohamed L. Sorror, MD MSc

Blood (2014) 124 (21): 2583.

https://doi.org/10.1182/blood.V124.21.2583.2583

Published: 2014

Journal Articles

The Outcome Of Allogeneic Hematopoietic Cell Transplantation In Children With FLT3/ITD-Positive Acute Myelogenous Leukemia

Tal Schechter, MD, Adam Gassas, MD, Heidi Chen, PhD, Jessica A. Pollard, MD, Soheil Meshinchi, MD, PhD, Zaidman Irina, MD, PhD, Johann K. Hitzler, MD, Mohamed M. Abdelhaleem, MD, PhD, FRCPC, Richard H. Ho, MD, MSCI, Jennifer Domm, MD, Ann E. Woolfrey, MD, Haydar A Frangoul, MD

Blood (2013) 122 (21): 2163.

https://doi.org/10.1182/blood.V122.21.2163.2163

Published: 2013

Journal Articles

Results Of a Phase I Study Of Clofarabine and 2 Gy Total Body Irradiation (TBI) As a Non-Myeloablative Preparative Regimen For Hematopoietic Stem Cell Transplantation (HSCT) In High Risk Children With Hematologic Malignancies: A Multi-Center TACL Study

Sandeep Soni, MD, Hisham Abdel-Azim, MD, Elena Eckroth, CCRC, Jeanette van der Geissen, BA, CCRP, Meghann Pine McManus, DO, MPH, Eneida R. Nemecek, MD, Richard Sposto, PhD, Blythe Thompson, MD, Ann E Woolfrey, MD, Haydar A Frangoul, MD

Blood (2013) 122 (21): 3286.

https://doi.org/10.1182/blood.V122.21.3286.3286

Published: 2013

Journal Articles

Sorafenib Treatment Following Hematopoietic Stem Cell Transplant In Pediatric FLT3/ITD+ AML

Jessica Pollard, MD, Bill H Chang, MD, PhD, Todd Michael Cooper, Thomas Gross, MD, PhD, Sumit Gupta, MD, Phoenix A. Ho, MD, Suzanne M. McGoldrick, MD, Tanya C. Watt, MD, MSc, India Sisler, MD, Blythe Thomson, MD, Ann E Woolfrey, MD, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 3969.

https://doi.org/10.1182/blood.V122.21.3969.3969

Published: 2013

Journal Articles

Modulated Cyclophosphamide-Based In Vivo T-Cell Depletion Promotes Engraftment With Minimal Gvhd and Low Toxicity In Fanconi Anemia Patients

Monica S Thakar, MD, Mark C. Walters, MD, Brenda M. Sandmaier, MD, Rainer Storb, MD, Mary E. D. Flowers, MD, H. Joachim Deeg, MD, Paul O'Donnell, MD, PhD, Ann E. Woolfrey, MD, Hans-Peter Kiem, MD

Blood (2013) 122 (21): 4561.

https://doi.org/10.1182/blood.V122.21.4561.4561

Published: 2013

Journal Articles

Influence Of Killer Immunoglobulin-Like Receptor (KIR) and HLA Genotypes On Outcomes After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation For Patients With AML and MDS: A Report From The Center For International Blood and Marrow Transplant Research Immunobiology Working Committee

Ronald M. Sobecks, MD, Meighan M. Gallagher, BA, Medhat Askar, MD, PhD, Michael D. Haagenson, MS, Tao Wang, PhD, Stephen Spellman, MBS, Stephanie J. Lee, MD, MPH, Marcelo A. Fernandez Viña, PhD, D(ABHI), Carlheinz R. Muller, MD, PhD, Michael R. Verneris, MD, Ann E. Woolfrey, MD, Peter J. Shaw, MD, Daniel J. Weisdorf, MD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Katharine C. Hsu, MD, PhD

Blood (2013) 122 (21): 159.

https://doi.org/10.1182/blood.V122.21.159.159

Published: 2013

Journal Articles

Results Of The Large Prospective Study On The Use Of Defibrotide (DF) In The Treatment Of Hepatic Veno-Occlusive Disease (VOD) In Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome - Updated Results Of a Treatment IND (T-IND) Expanded Access Protocol

Blood (2013) 122 (21): 700.

https://doi.org/10.1182/blood.V122.21.700.700

Published: 2013

Journal Articles

Sub-Morphologic Evidence of Disease Prior to Stem Cell Transplantation Correlates with Inferior Post Transplant Outcome in Childhood Acute Myeloid Leukemia.

Abby R. Rosenberg, MD, Wendy Leisenring, Sc.D., Jean E Sanders, MD, Ann E Woolfrey, MD, Paul A. Carpenter, MD, Denise A. Wells, MD, Michael R. Loken, PhD, Soheil Meshinchi, MD, PhD

Blood (2009) 114 (22): 328.

https://doi.org/10.1182/blood.V114.22.328.328

Published: 2009

Journal Articles

Decreased Relapse Rates without Excessive Transplant Related Mortality Following Cord Blood Transplantation (CBT): A Matched Cohort Analysis Comparing Myeloablative Cord, Matched Unrelated, and Mismatched Unrelated Donor Transplants.

Jonathan A Gutman, MD, Wendy Leisenring, Sc.D., Frederick R. Appelbaum, MD, Ann E Woolfrey, MD, Colleen Delaney, MD, MSC

Blood (2008) 112 (11): 968.

https://doi.org/10.1182/blood.V112.11.968.968

Published: 2008

Journal Articles

Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome.

Franco Locatelli, MD, PhD, Adrienne Moreno-Madureira, MD, Pierre Teira, MD, Mary Eapen, MBBS, Mei-Jie Zhang, PhD, Stella M. Davies, MBBS, PhD, Alessandra Picardi, MD, Ann E Woolfrey, MD, Ka Wah Chan, MBBS, Gerard Socie, MD, Ajay J. Vora, Yves Bertrand, Joanne Kurtzberg, MD, Carmen Bonfim, MD, Eliane Gluckman, MD, Charlotte M Niemeyer, MD, PhD, Vanderson Rocha, MD, PhD

Blood (2008) 112 (11): 1964.

https://doi.org/10.1182/blood.V112.11.1964.1964

Published: 2008

Journal Articles

A Regimen of Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for High-Risk Hematologic Malignancies Is Associated with Low Treatment-Related Mortality

Eneida R. Nemecek, MD, Mohamed L. Sorror, MD, MS, Kristine C. Doney, MD, Bart Lee Scott, MD, Tibor J. Kovacsovics, MD, Richard Thomas Maziarz, MD, Ann E Woolfrey, MD, Jean Sanders, MD, Paul V. O’Donnell, Katherine Guthrie, PhD, H. Joachim Deeg, MD

Blood (2008) 112 (11): 2994.

https://doi.org/10.1182/blood.V112.11.2994.2994

Published: 2008

Journal Articles

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

Ann E Woolfrey, MD, John Klein, PhD, Michael D Haagenson, MS, Stephen R Spellman, MS, Minoo Battiwalla, MD, James L. Gajewski, MD, Gregory A. Hale, MD, John Horan, MD, MPH, Carolyn K Hurley, PhD, Craig Kollman, PhD, Susana Marino, MD, PhD, Machteld Oudshoorn, PhD, Effie W Petersdorf, MD, Olle Ringdén, MD, PhD, Michelle Setterholm, Stephanie J. Lee, MD, MPH

Blood (2008) 112 (11): 563.

https://doi.org/10.1182/blood.V112.11.563.563

Published: 2008

Journal Articles

Monitoring for HLA Antibodies in Cord Blood Transplantation.

Jonathan A. Gutman, MD, Susan K. McKinney, Sandra L. Warnock, Anajane Smith, MS, Ann E. Woolfrey, MD, John A. Hansen, MD, Colleen Delaney, MD, MSc

Blood (2007) 110 (11): 2031.

https://doi.org/10.1182/blood.V110.11.2031.2031

Published: 2007

Journal Articles

Outcomes in the Recent Seattle Cord Blood Experience: Low TRM and Relapse; High Mild Acute GVHD and CMV Reactivation.

Jonathan A. Gutman, MD, Ann E. Woolfrey, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Jean E. Sanders, MD, Colleen Delaney, MD, MSc

Blood (2007) 110 (11): 2019.

https://doi.org/10.1182/blood.V110.11.2019.2019

Published: 2007

NARROW

Gene Therapy for Fanconi Anemia in Seattle: Clinical Experience and Next Steps

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

5 Year Results of BMT CTN 0201: Unrelated Donor Bone Marrow Is Associated with Better Psychological Well-Being and Less Burdensome Chronic Gvhd Symptoms Than Peripheral Blood

Minimal Residual Disease Does Not Impact Risk of Relapse in Myeloablative Umbilical Cord Blood Transplant Recipients: Comparison with Matched and Mismatched Unrelated Transplants

Role of Comorbidities in Prognostic Evaluation of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-Mismatched (MM) and Umbilical Cord Blood (UCB) Donor Grafts

The Outcome Of Allogeneic Hematopoietic Cell Transplantation In Children With FLT3/ITD-Positive Acute Myelogenous Leukemia

Results Of a Phase I Study Of Clofarabine and 2 Gy Total Body Irradiation (TBI) As a Non-Myeloablative Preparative Regimen For Hematopoietic Stem Cell Transplantation (HSCT) In High Risk Children With Hematologic Malignancies: A Multi-Center TACL Study

Sorafenib Treatment Following Hematopoietic Stem Cell Transplant In Pediatric FLT3/ITD+ AML

Modulated Cyclophosphamide-Based In Vivo T-Cell Depletion Promotes Engraftment With Minimal Gvhd and Low Toxicity In Fanconi Anemia Patients

Results Of The Large Prospective Study On The Use Of Defibrotide (DF) In The Treatment Of Hepatic Veno-Occlusive Disease (VOD) In Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome - Updated Results Of a Treatment IND (T-IND) Expanded Access Protocol

Sub-Morphologic Evidence of Disease Prior to Stem Cell Transplantation Correlates with Inferior Post Transplant Outcome in Childhood Acute Myeloid Leukemia.

Decreased Relapse Rates without Excessive Transplant Related Mortality Following Cord Blood Transplantation (CBT): A Matched Cohort Analysis Comparing Myeloablative Cord, Matched Unrelated, and Mismatched Unrelated Donor Transplants.

Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome.

A Regimen of Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for High-Risk Hematologic Malignancies Is Associated with Low Treatment-Related Mortality

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

Monitoring for HLA Antibodies in Cord Blood Transplantation.

Outcomes in the Recent Seattle Cord Blood Experience: Low TRM and Relapse; High Mild Acute GVHD and CMV Reactivation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only